• Tariquidar and the Tumor Mechanical Microenvironment: New Fr

  2026-07-15

  Explore how Tariquidar (XR9576) uniquely empowers drug resistance research by targeting P-glycoprotein in the context of tumor microenvironment mechanics. This article offers a deeper analysis of mechanotransduction-driven chemoresistance and advanced strategies for transporter inhibition.

• CCT007093: PPM1D Inhibitor Workflows for P38 MAPK Dissection

  2026-07-15

  CCT007093 stands out as a selective PPM1D inhibitor, unlocking high-precision dissection of the P38 MAPK pathway in both cancer and acute kidney injury models. Its selective cytotoxicity and robust pathway modulation capabilities make it a top choice for researchers aiming to unravel PPM1D-mediated signaling dynamics.

• Toremifene: Selective Estrogen-Receptor Modulator in Prostat

  2026-07-14

  Toremifene enables precise modulation of estrogen receptor pathways in prostate cancer research, supporting advanced cell-based and in vivo assays. Its well-characterized inhibition profile and compatibility with hormone-responsive models make it a trusted choice for dissecting complex metastatic mechanisms.

• SM-102 for mRNA Delivery: Protocols & Tumor Suppressor Thera

  2026-07-14

  SM-102, a high-purity synthetic lipid, enables robust mRNA delivery via lipid nanoparticles, unlocking advanced workflows for localized cancer therapy. This article translates cutting-edge reference findings into actionable protocols and troubleshooting strategies for mRNA vaccine and therapeutic research.

• O-GlcNAcylation Links Wnt Signaling to Glycolytic Bone Forma

  2026-07-13

  This study uncovers how Wnt3a-induced O-GlcNAcylation orchestrates aerobic glycolysis and osteoblast-driven bone formation. The findings reveal a metabolic mechanism underlying Wnt-stimulated bone anabolism, with implications for osteoporosis therapy and Wnt pathway research.

• Dibutyryl-cAMP, Sodium Salt: Precision Tools for Tauopathy R

  2026-07-13

  Explore how Dibutyryl-cAMP, sodium salt empowers advanced cAMP signaling pathway research and tauopathy modeling. Uncover mechanistic insights, rigorous protocol guidance, and distinct scientific perspectives for neurodegeneration studies.

• Meropenem: β-Lactam Antibiotic Carbapenem for Research Use

  2026-07-12

  Meropenem is an ultra-broad-spectrum β-lactam antibiotic carbapenem with activity against diverse Gram-negative and Gram-positive bacteria. Its validated mechanism centers on penicillin-binding protein inhibition, resulting in rapid bactericidal action. APExBIO's Meropenem (SKU A5124) is widely adopted for translational resistance and septicemia research models.

• GSK126 EZH2 Inhibitor: Expanding Beyond Oncology with PRC2 M

  2026-07-10

  Explore how the GSK126 EZH2 inhibitor advances cancer epigenetics research and opens new frontiers in stem cell biology by targeting PRC2. This article delivers a deeper, evidence-driven perspective on experimental design and biological implications.

• HO-1-Mediated ROS Modulation Impairs HBV Replication: Study

  2026-07-09

  A recent study demonstrates that isochlorogenic acid A (ICAA) disrupts hepatitis B virus (HBV) replication by upregulating heme oxygenase-1 (HO-1) and altering intracellular reactive oxygen species (ROS) levels. These findings highlight new antiviral mechanisms involving HO-1 pathways and provide fresh directions for metabolic and virological research.

• Dual-Targeted Trilaurin Lipid Nanoparticles for Local Colon

  2026-07-09

  This study introduces a microfluidized dextran microgel system encapsulating cisplatin and SPION-loaded trilaurin lipid nanoparticles (LNPs) for precise oral delivery to colon tumors. The dual-targeting design, leveraging both dextran and folic acid, achieves enhanced colon retention, selective tumor uptake, and significant tumor growth inhibition via combined chemo-magnetothermal therapy.

• Tariquidar (XR9576): Applied Workflows for ABC Transporter I

  2026-07-08

  Tariquidar (XR9576) empowers researchers to dissect and overcome cancer drug resistance driven by P-glycoprotein, with unique efficacy in high-viscosity microenvironments. Discover stepwise protocols, advanced troubleshooting, and critical insights from recent mechanobiology research.

• GANT61 Induces Apoptosis in ALK+ ALCL via Hh-PIK3IP1-Akt Mod

  2026-07-08

  This study reveals that GANT61, a Gli1/2 inhibitor, suppresses proliferation and triggers apoptosis in ALK-positive anaplastic large cell lymphoma (ALK+ ALCL) by modulating the Hedgehog (Hh) and PI3K/Akt signaling pathways. The findings identify the Hh-PIK3IP1-Akt axis as a potential target for novel therapies and provide a mechanistic basis for Gli1-directed intervention in this lymphoma subtype.

• ABT-263 (Navitoclax): High-Affinity Bcl-2 Family Inhibitor i

  2026-07-07

  ABT-263 (Navitoclax) is a potent, orally bioavailable Bcl-2 family inhibitor used to induce caspase-dependent apoptosis in cancer biology research. It shows nanomolar affinity for Bcl-2, Bcl-xL, and Bcl-w, and is validated in pediatric leukemia and colorectal cancer models. Its precise mechanism and solubility profile make it a benchmark tool for apoptosis assay workflows.

• Phosbind Biotin LC: Practical Guide for Western Blot Phospho

  2026-07-07

  Phosbind Biotin LC addresses the challenge of detecting phosphorylated proteins in Western Blot assays when phospho-specific antibodies are unavailable, unreliable, or limited by sequence specificity. It is not suitable for aqueous-only protocols or for workflows requiring long-term storage of prepared solutions.

• Strategic Membrane Labeling: DiD (DiDC 18 (5)) in Translatio

  2026-07-06

  This thought-leadership article explores how DiD (DiDC 18 (5)) transforms cell membrane labeling and cell tracking in complex inflammatory and high-autofluorescence contexts. By integrating mechanistic insights from ROS-driven macrophage pathology and advanced hydrogel delivery platforms, we provide translational researchers with evidence-backed guidance, protocol optimization, and a vision for next-generation disease modeling using APExBIO’s DiD probe.

446 records 11/30 page Previous Next First page 上5页 1112131415 下5页 Last page